pharmacy benefit managers

Controversy heats up over pharmacy benefit manager DIR feesPBMs make the argument for DIR fees after a litany of complaints from industry stakeholders.
Drug Spending Slows for Major Pharmacy Benefit Managers
Expedited FDA approval plays dominant role in drug approvalsLast year was a banner year for generic drug approvals by the FDA. Find out what’s in store for 2017.
Pharmacists Pushing for DIR Relief
Pharmacists Pushing for DIR ReliefCommunity pharmacists fight against financial pressure for their survival.
Health execs must brace for autoimmune drug changesA comprehensive understanding of this rapidly increasing drug class is essential to integrate pharmacy and medical claim information.
Walgreens-Prime alliance: A new breed pharmacy strategy?This model, touted as “next-generation,” combines retail and specialty and mail services and PBM along with immediate care clinics.
Top 4 pharmacy trends healthcare executives should watch
Top 4 pharmacy trends healthcare executives should watchManaged Healthcare Executive conducted its first-ever managed care pharmacy survey during the second quarter of 2016 in partnership with Access Market Intelligence. Here’s a look at some of the key findings, with experts weighing in on the results.
Drug spending rising at slower pacePBM Express Scripts shares findings from its new Drug Trend Report.
CMS unveils enhanced MTM program
CMS unveils enhanced MTM programModel set to improve compliance, reduce costs, but reimbursement challenges remain.
Specialty pharmacies: The payer’s dilemma
Specialty pharmacies: The payer’s dilemmaPayers weigh the benefits of using their own resources to develop a specialty pharmacy or contracting outside for services.